ANSDELL HOUSE CLINIC LIMITED
Opportunity 78/100 (strong), bankability 75/100. Strong seller-intent signal (68/100, director aged 75). Share purchase looks the cleaner deal structure. Biggest value-creation lever: Broaden director team. Sole director creates succession risk and reduces buyer comfort. Appoint a second director or strong #2. Most likely exit: share sale to pe / searcher (73/100).
Data confidence
Overall: medium (76/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Solid opportunity signal. Worth a dedicated memo and management meeting.
Key financials
2 years extracted from filed iXBRL accountsHover to see exact values · click legend to toggle series
Financials
Extracted from Companies House accounts · FRS 102| Metric | 2025-03-31 | 2024-03-31 |
|---|---|---|
| Average employees | 1 | 100 |
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.
Available from the Pro tier upwards.
See pricing →Recent activity
Corporate timeline (18 events)Click to expand
- 2025-11-10📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2024-12-13📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2023-10-02📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2023-03-31📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2021-08-27📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2020-12-18📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2020-02-05📄capital-allotment-sharescapital · SH01
- 2019-12-20📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2018-12-06📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2017-12-20📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2016-12-30📄accounts-with-accounts-type-total-exemption-smallaccounts · AA
- 2015-12-31📄accounts-with-accounts-type-total-exemption-smallaccounts · AA
- 2015-12-22📄annual-return-company-with-made-up-date-full-list-shareholdersannual-return · AR01
- 2015-01-10📄annual-return-company-with-made-up-date-full-list-shareholdersannual-return · AR01
- 2015-01-10📄change-person-secretary-company-with-change-dateofficers · CH03
- 2012-10-26🏢Company incorporatedAs ANSDELL HOUSE CLINIC LIMITED
- 2012-10-26➕EDWARDS, Heather Pearl appointedsecretary
- 2012-10-26➕GOODMAN EDWARDS, Robert John appointeddirector
Owner dependency
The business appears inseparable from the founder. Acquisition without a serious earn-out or meaningful transition period would likely destroy value.
- +Sole director: Only one active director — all governance concentrated on one person.
- +Founder age: Director aged approximately 75 — succession pressure is live.
- +No director turnover: Company is 14 years old with no director changes — suggests a very tight-knit founder team never broadened.
Succession & seller-readiness
Strong acquirability signals converging. Worth approaching directly — this is how off-market deals start.
- primaryFounder aged 70+: Senior director is approximately 75 years old. Natural succession window is now.
- primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.
- secondary12+ year tenure: Director in role 14 years.
- supportingClean filings + long tenure: Disciplined long-tenure operator — classic lifestyle-business pattern that often sells quietly.
Red flags
cleanShareholders & ownership
1 active beneficial owner · dominant holder ≥75%| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Mr Robert John Goodman Edwards Individual · British · DOB 02/1951 · age 75 | 75–100% | — | 75-100% shares | 06/04/2016 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Similar companies
Active · Healthcare & medical · PR postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| AL PHYSIOTHERAPY LTD→ 15479009 · est 2024 · no financials extracted | — | — | — | — | 2y | — | — |
| ALCEDO GREEN LIMITED→ 11806625 · est 2019 · no financials extracted | — | — | — | — | 7y | — | — |
| AMA OPTICAL LTD→ 11461010 · est 2018 · no financials extracted | — | — | — | — | 7y | — | — |
| AMISA CO. LTD→ 07002798 · est 2009 · no financials extracted | — | — | — | — | 16y | — | — |
| AMZN LTD→ 15491416 · est 2024 · no financials extracted | — | — | — | — | 2y | — | — |
| ANA UM LTD→ 12616214 · est 2020 · no financials extracted | — | — | — | — | 5y | — | — |
| ANDREW WARDLEY LIMITED→ 08912928 · est 2014 · no financials extracted | — | — | — | — | 12y | — | — |
| ANNAMARIYA LIMITED→ 11717319 · est 2018 · no financials extracted | — | — | — | — | 7y | — | — |
| ANOUSHVIVAAN GP SERVICE LTD→ 16132623 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| ANWAR ZAMAN LTD→ 07212020 · est 2010 · no financials extracted | — | — | — | — | 16y | — | — |
| ANZUPHARM LTD→ 14626773 · est 2023 · no financials extracted | — | — | — | — | 3y | — | — |
| AOZ LIMITED→ 16361282 · est 2025 · no financials extracted | — | — | — | — | 1y | — | — |
8 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (2 active · 0 resigned)
Click a director name to see their full track record across all companies.